Molecular mechanisms and clonal distribution of cefiderocol-resistant blaNDM-carrying Escherichia coli: a multi-centre study in China - PubMed
4 hours ago
- #Escherichia coli
- #blaNDM
- #Cefiderocol resistance
- Cefiderocol resistance is increasing globally, including in China, despite its unavailability there.
- blaNDM-carrying Escherichia coli is a major pathogen causing cefiderocol resistance, with a resistance rate of 50.5% in the study.
- High-level resistance is due to multiple mechanisms, including blaNDM production and CirA-frameshift mutation/PBP3 insertion.
- No additional fitness cost was observed in CirA/PBP3 mutants.
- 20 homologous strains were identified, indicating possible clonal transmission and hospital outbreaks.
- Resistance-related mutations (CirA-frameshift mutations/I547F and PBP3-Q227H, YRIN333ins, E349K, I532L) were co-occurring and concentrated in certain lineages.
- Diverse sources suggest potential spread of resistant strains among humans, animals, and the environment.
- Genetic distribution of resistant isolates is associated with their geographical origins.
- The study highlights the need for a 'One Health' strategy to address cefiderocol resistance.